SMEDI Co., Ltd.

A118000

KR7118000009

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
560 ^KRW	+6.46%		+9.38%	+40.00%

03-20	SMEDI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-19	THE MEDIPHARM CO.,Ltd. cancelled the acquisition of 17.19% stake in INFOMARK Co., Ltd from THE MEDIPHARM CO.,Ltd..	CI

Wooridul Huebrain Limited announced that it has received KRW 11.06000082 billion in funding

May 25, 2022

On May 26, 2022, Wooridul Huebrain Limited closed the transaction.

Latest news about SMEDI Co., Ltd.

SMEDI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
THE MEDIPHARM CO.,Ltd. cancelled the acquisition of 17.19% stake in INFOMARK Co., Ltd from THE MEDIPHARM CO.,Ltd..	01-18	CI
SMEDI Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Chorokbaem Media Co., Ltd. acquired a 32.05% stake in THE MEDIPHARM CO.,Ltd. from Green Lusk Fund and others	23-08-24	CI
THE MEDIPHARM CO.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
THE MEDIPHARM CO.,Ltd. agreed to acquire 17.19% stake in INFOMARK Co., Ltd from THE MEDIPHARM CO.,Ltd. for KRW 22 billion.	23-07-03	CI
THE MEDIPHARM CO.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
INFOMARK Co., Ltd announced that it has received KRW 23.00003656 billion in funding from L Fin Company Co., Ltd., ITEX, Inc., Kukdong Corporation, Teladin Co., Ltd., Wooridul Huebrain Limited	22-12-28	CI
INFOMARK Co., Ltd announced that it expects to receive KRW 23.00003656 billion in funding from L Fin Company Co., Ltd., ITEX, Inc., Kukdong Corporation, Teladin Co., Ltd., Wooridul Huebrain Limited	22-12-20	CI
Wooridul Huebrain Limited agreed to acquire an additional 34.91197% stake in INFOMARK Co., Ltd for KRW 14 billion.	22-12-20	CI
Wooridul Huebrain Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Wooridul Huebrain Limited(KOSE:A118000) dropped from S&P Global BMI Index	22-09-19	CI
Wooridul Huebrain Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Wooridul Huebrain Limited agreed to acquire an additional 2.754106% stake in INFOMARK Co., Ltd for KRW 3.6 billion	22-05-29	CI
Wooridul Huebrain Limited announced that it has received KRW 11.06000082 billion in funding	22-05-25	CI
Wooridul Huebrain Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Wooridul Huebrain Limited announced that it expects to receive KRW 13.00000086 billion in funding	22-05-12	CI
SKY E&M Co., Ltd. acquire ChorokbaemFoodFarm Co., Ltd. from Alpha Bio Labs Inc, Rumios Co., Ltd, Wooridul Huebrain Limited, Abraxas Fund Limited, Chorokbaem Media Co., Ltd. and others for approximately KRW 48,371 million	22-05-11	CI
SKY E&M Co., Ltd. announced that it has received KRW 40.000003225 billion in funding from Wooridul Huebrain Limited, Chorokbaem Media Co., Ltd.	22-05-10	CI
SKY E&M Co., Ltd. announced that it expects to receive KRW 38.900004192 billion in funding from Wooridul Huebrain Limited, Chorokbaem Media Co., Ltd.	22-04-25	CI
Wooridul Huebrain Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-21	CI
CHOROKBAEM COMPANY Co., Ltd. announced that it has received KRW 21.50000127 billion in funding from Wooridul Huebrain Limited, Ocean In W Co.,Ltd.	22-01-19	CI
CHOROKBAEM COMPANY Co., Ltd. announced that it expects to receive KRW 21.00000042 billion in funding from Wooridul Huebrain Limited	21-12-21	CI
INFOMARK Co., Ltd announced that it has received KRW 8.50000308 billion in funding from Wooridul Huebrain Limited	21-11-25	CI
Wooridul Huebrain Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI

SMeDi Co Ltd, formerly The MediPharm Co Ltd, is a Korea-based company primarily engaged in the pharmaceutical distribution business. The Company operates through five segments. The Pharmaceuticals Business segment is engaged in the distribution of pharmaceuticals including recapsules and tablets. The Medical Business segment is engaged in the distribution of medical devices and medical supplies. The Wireless Device segment is engaged in the manufacture of wearable wireless devices. The Video Content segment is engaged in the production of video products. The Investment segment is engaged in the management consulting and investment businesses.

Sector

Pharmaceuticals

Calendar

2024-11-12 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SMEDI CO., LTD.	+40.00%	59.09M
MCKESSON CORPORATION	+21.93%	73.38B
CARDINAL HEALTH, INC.	-1.71%	24.13B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+10.34%	8.59B
HUADONG MEDICINE CO., LTD	-19.80%	8.06B
H. LUNDBECK A/S	+14.16%	5.26B
EBOS GROUP LIMITED	-0.03%	4.21B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+12.70%	4.17B
GALENICA AG	-2.54%	3.89B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+24.00%	3.71B

Pharmaceuticals Wholesale

SMEDI Co., Ltd.

Equities

A118000

KR7118000009

Pharmaceuticals

Wooridul Huebrain Limited announced that it has received KRW 11.06000082 billion in funding

Latest news about SMEDI Co., Ltd.

Chart SMEDI Co., Ltd.

Company Profile

Income Statement Evolution

Sector Pharmaceuticals Wholesale